Microdosing tirzepatide vs. semaglutide: How the two compare

Introduction: Two GLP-1 medications, one clinician-guided approach

Tirzepatide and semaglutide are the two most discussed GLP-1 medications, and both are available through Luvo's Microdosing Program. They aren't identical, and understanding how they differ can help you have a more informed conversation with a provider.

This is an educational overview. It isn't medical advice or a promise of a specific result.

How they work

Semaglutide is a GLP-1 receptor agonist: it mimics the GLP-1 hormone released after eating, reducing appetite, slowing gastric emptying, and supporting blood-sugar regulation. Tirzepatide is a dual GIP/GLP-1 receptor agonist, acting on a second pathway as well. This difference in mechanism is a factual distinction, not a claim about which produces a better result for any individual.

The microdosing approach applies to both

For either medication, a microdosing approach means working with a lower-than-standard dose under provider guidance and adjusting based on response, rather than automatically reaching the maximum. Whether either medication, and what dose, is appropriate is a clinical decision.

Side effects and tolerability

Both medications share broadly similar side-effect profiles, most commonly gastrointestinal (nausea, diarrhea, constipation). Individual responses vary, and some people tolerate one better than the other, which is one reason Luvo offers both. Both have important contraindications a provider screens for, including a personal or family history of medullary thyroid carcinoma or MEN 2.

Injection or tablet, and choosing with a provider

Luvo offers microdosing tirzepatide as an injection, and microdosing semaglutide as either an injection or a tablet. There's no universal better choice between tirzepatide and semaglutide; the right option depends on your health history, tolerance, preference for injection versus oral dosing, and availability. Both are prescription medications, and Luvo's compounded versions are not FDA-approved; a licensed provider reviews your history and helps you decide. Explore Luvo's microdosing tirzepatide injection and microdosing semaglutide injection and tablet options.